CCEL logo

Cryo-Cell International (CCEL) Return On Equity

Annual ROE

86.32%
-122.06%-58.58%

November 30, 2023

Summary

Performance

1-Year Change

-58.58%

3-Year Change

+163.47%

5-Year Change

+799.17%

15-Year Change

+566.09%

CCEL ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

89.65%
CCEL annual return on equity is higher than 89.65% of companies in Healthcare sector

High & Low

All-time High

274.30%
CCEL annual return on equity is currently -68.53% below its historical high of 274.30%

3-Year Low

86.32%
CCEL annual return on equity is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Nov 30, 2023
CCEL previous annual earnings announcement was published on Nov 30, 2023

Next Annual Earnings Report Date

Feb 28, 2025
CCEL next annual earnings announcement is scheduled for Feb 28, 2025

OtherCCELprofitabilitymetrics:

Annual Revenue

$31.34 M
CCEL annual revenue is $31.34 million

Annual Net Income

-$9.52 M
CCEL annual net profit is -$9.52 million

Annual EPS

-$1.14
CCEL annual earnings per share is -$1.14

Annual ROA

-15.10%
CCEL annual return on assets is -15.10%

Quarterly ROE

85.69%
-30.07%-25.98%

August 1, 2024

Summary

Performance

3-Month Change

-25.98%

1-Year Change

-71.67%

3-Year Change

-71.67%

5-Year Change

-71.67%

CCEL Quarterly ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

90.68%
CCEL quarterly return on equity is higher than 90.68% of companies in Healthcare sector

High & Low

All-time High

4836.75%
CCEL quarterly return on equity is currently -98.23% below its historical high of 4836.75%

3-Year Low

-324.81%

Earnings dates

Last Quarterly Earnings Report Date

Aug 1, 2024
CCEL previous earnings announcement was published on Aug 1, 2024

Next Quarterly Earnings Report Date

Feb 28, 2025
CCEL next earnings announcement is scheduled for Feb 28, 2025

OtherCCELprofitabilitymetrics:

Quarterly Revenue

$8.07 M
CCEL quarterly revenue is $8.07 million

Quarterly Net Income

$1.05 M
CCEL quarterly net profit is $1.05 million

Quarterly EPS

$0.13
CCEL quarterly earnings per share is $0.13

Quarterly ROA

-14.03%
CCEL quarterly return on assets is -14.03%

ROE Formula

ROE =  Net Income
Shareholders Equity ✕ 100%

Annual ROE

86.32%
CCEL annual return on equity is 86.32%

Annual Net Income

-$9.52 M
CCEL annual net profit is -$9.52 million

Annual Shareholders Equity

-$11.03 M
CCEL annual stockholders equity is -$11.03 million

CCEL ROE Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-58.6%-71.7%
3 y3 years+163.5%-71.7%
5 y5 years+799.2%-71.7%

CCEL ROE Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-68.5%at low-74.3%+126.4%
5 y5-year-68.5%+163.5%-98.2%+124.5%
alltimeall time-68.5%+125.0%-98.2%+106.8%

Cryo-Cell International ROE History

DateAnnualQuarterly
Aug 2024
-
85.69%(-26.0%)
May 2024
-
115.76%(-33.9%)
Feb 2024
-
175.01%(-42.1%)
Nov 2023
86.32%(-58.6%)
302.43%(-193.1%)
Aug 2023
-
-324.81%(+93.3%)
May 2023
-
-168.07%(-150.4%)
Feb 2023
-
333.20%(+114.8%)
Nov 2022
208.38%(-24.0%)
155.13%(+265.1%)
Aug 2022
-
42.49%(+9.1%)
May 2022
-
38.95%(-45.5%)
Feb 2022
-
71.48%(-40.8%)
Nov 2021
274.30%(-301.7%)
120.77%(-97.5%)
Aug 2021
-
4836.75%(-1480.4%)
May 2021
-
-350.39%(+222.8%)
Feb 2021
-
-108.56%(+32.4%)
Nov 2020
-136.00%(+312.7%)
-81.98%(+37.7%)
Aug 2020
-
-59.53%(+2.9%)
May 2020
-
-57.86%(+49.9%)
Feb 2020
-
-38.59%(+27.4%)
Nov 2019
-32.95%(-443.2%)
-30.30%(+4.4%)
Aug 2019
-
-29.03%(+73.7%)
May 2019
-
-16.71%(-12.0%)
Feb 2019
-
-18.99%(-362.3%)
Nov 2018
9.60%(-151.8%)
7.24%(-13.8%)
Aug 2018
-
8.40%(+73.2%)
May 2018
-
4.85%(-5.8%)
Feb 2018
-
5.15%(-130.7%)
Nov 2017
-18.52%(-316.1%)
-16.80%(-0.4%)
Aug 2017
-
-16.86%(-405.4%)
May 2017
-
5.52%(+0.9%)
Feb 2017
-
5.47%(-56.1%)
Nov 2016
8.57%(-105.2%)
12.47%(-57.6%)
Aug 2016
-
29.44%(-117.9%)
May 2016
-
-164.68%(+38.1%)
Feb 2016
-
-119.23%(+13.1%)
Nov 2015
-163.30%(+3064.7%)
-105.39%(+19.9%)
Aug 2015
-
-87.93%(+2008.6%)
May 2015
-
-4.17%(-3.5%)
Feb 2015
-
-4.32%(-22.3%)
Nov 2014
-5.16%(+1620.0%)
-5.56%(-21.9%)
Aug 2014
-
-7.12%(+3.6%)
May 2014
-
-6.87%(+252.3%)
Feb 2014
-
-1.95%(+550.0%)
Nov 2013
-0.30%(-100.4%)
-0.30%(-104.1%)
Aug 2013
-
7.25%(-54.1%)
May 2013
-
15.79%(-69.6%)
Feb 2013
-
51.94%(-39.3%)
Nov 2012
70.11%(-17.7%)
85.62%(-12.0%)
Aug 2012
-
97.28%(-43.8%)
May 2012
-
173.25%(+5.9%)
Feb 2012
-
163.60%(+13.6%)
Nov 2011
85.17%(-124.6%)
144.00%(-3.6%)
Aug 2011
-
149.36%(-147.7%)
May 2011
-
-312.90%(+88.7%)
Feb 2011
-
-165.80%(+46.4%)
Nov 2010
-345.83%
-113.29%(+66.5%)
DateAnnualQuarterly
Aug 2010
-
-68.04%(+285.7%)
May 2010
-
-17.64%(-26.6%)
Feb 2010
-
-24.02%(-6.4%)
Nov 2009
-27.50%(-358.7%)
-25.65%(-16.0%)
Aug 2009
-
-30.52%(+64.4%)
May 2009
-
-18.56%(+1587.3%)
Feb 2009
-
-1.10%(-110.5%)
Nov 2008
10.63%(-86.0%)
10.51%(-70.7%)
Aug 2008
-
35.93%(-33.4%)
May 2008
-
53.95%(-32.2%)
Feb 2008
-
79.57%(-26.5%)
Nov 2007
75.95%(-43.5%)
108.29%(-11.2%)
Aug 2007
-
121.95%(-26.3%)
May 2007
-
165.50%(-28.2%)
Feb 2007
-
230.43%(-37.4%)
Nov 2006
134.38%(-48.7%)
368.29%(-70.0%)
Aug 2006
-
1229.64%(-1767.3%)
May 2006
-
-73.75%(-102.9%)
Feb 2006
-
2563.98%(-303.5%)
Nov 2005
261.89%(-177.1%)
-1260.24%(+367.3%)
Aug 2005
-
-269.66%(-16.9%)
May 2005
-
-324.51%(+56.1%)
Feb 2005
-
-207.90%(+54.4%)
Nov 2004
-339.84%(-271.3%)
-134.65%(-323.2%)
Aug 2004
-
60.32%(-67.3%)
May 2004
-
184.65%(-61.6%)
Feb 2004
-
481.06%(-159.5%)
Nov 2003
198.41%(-399.0%)
-808.54%(+380.0%)
Aug 2003
-
-168.44%(+61.0%)
May 2003
-
-104.65%(+49.1%)
Feb 2003
-
-70.18%(+43.3%)
Nov 2002
-66.36%(-880.7%)
-48.96%(+354.6%)
Aug 2002
-
-10.77%(+1582.8%)
May 2002
-
-0.64%(-106.0%)
Feb 2002
-
10.61%(+12.3%)
Nov 2001
8.50%(-133.2%)
9.45%(+927.2%)
Aug 2001
-
0.92%(-114.2%)
May 2001
-
-6.49%(-69.7%)
Feb 2001
-
-21.44%(-8.8%)
Nov 2000
-25.62%(+51.6%)
-23.51%(+455.8%)
Aug 2000
-
-4.23%(-25.7%)
May 2000
-
-5.69%(+344.5%)
Feb 2000
-
-1.28%(-57.0%)
Nov 1999
-16.90%(-80.9%)
-2.98%(-96.2%)
Aug 1999
-
-79.31%(+21.6%)
May 1999
-
-65.22%(-21.1%)
Feb 1999
-
-82.71%(-5.8%)
Nov 1998
-88.46%(+88.0%)
-87.79%(+64.6%)
Aug 1998
-
-53.33%(-21.9%)
May 1998
-
-68.32%(+18.2%)
Feb 1998
-
-57.80%(+31.5%)
Nov 1997
-47.06%(-390.1%)
-43.96%(+38.3%)
Aug 1997
-
-31.79%(+17.6%)
May 1997
-
-27.03%(-593.2%)
Feb 1997
-
5.48%(-66.2%)
Nov 1996
16.22%
16.22%

FAQ

  • What is Cryo-Cell International annual return on equity?
  • What is the all time high annual ROE for Cryo-Cell International?
  • What is Cryo-Cell International annual ROE year-on-year change?
  • What is Cryo-Cell International quarterly return on equity?
  • What is the all time high quarterly ROE for Cryo-Cell International?
  • What is Cryo-Cell International quarterly ROE year-on-year change?

What is Cryo-Cell International annual return on equity?

The current annual ROE of CCEL is 86.32%

What is the all time high annual ROE for Cryo-Cell International?

Cryo-Cell International all-time high annual return on equity is 274.30%

What is Cryo-Cell International annual ROE year-on-year change?

Over the past year, CCEL annual return on equity has changed by -122.06% (-58.58%)

What is Cryo-Cell International quarterly return on equity?

The current quarterly ROE of CCEL is 85.69%

What is the all time high quarterly ROE for Cryo-Cell International?

Cryo-Cell International all-time high quarterly return on equity is 4836.75%

What is Cryo-Cell International quarterly ROE year-on-year change?

Over the past year, CCEL quarterly return on equity has changed by -216.74% (-71.67%)